Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS??? EQUITY

v3.8.0.1
CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY - 9 months ended Sep. 30, 2017 - USD ($)
Total
Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Balance at Dec. 31, 2016 $ 17,721,837 $ 50 $ 19,569 $ 94,541,168 $ (76,838,950)
Balance (in shares) at Dec. 31, 2016   49,626 19,569,247    
Conversion of Note Payable & Accrued Interest 1,861,283   $ 827 1,860,456  
Conversion of Note Payable & Accrued Interest (in shares)     827,237    
Exercise of Warrants 0   $ 168 (168)  
Exercise of Warrants (in shares)     168,203    
Stock Based Compensation Expense 912,102   $ 10 912,092  
Stock Based Compensation Expense (in shares)     10,420    
Exercise of Stock Options 0   $ 37 (37)  
Exercise of Stock Options (in shares)     37,261    
Common Stock Issued for Services 100,000   $ 17 99,983  
Common Stock Issued for Services (in shares)     16,543    
Common Stock Awards to Directors 335,000   $ 50 334,950  
Common Stock Awards to Directors (in shares)     50,000    
Proceeds from Common Stock Offerings 8,628,500   $ 1,500 8,627,000  
Proceeds from Common Stock Offerings (in shares)     1,500,000    
Direct Costs of Common Stock Offerings (650,179)     (650,179)  
Net Loss for the Nine Months Ended September 30, 2017 (13,754,038)       (13,754,038)
Balance at Sep. 30, 2017 $ 15,154,505 $ 50 $ 22,178 $ 105,725,265 $ (90,592,988)
Balance (in shares) at Sep. 30, 2017   49,626 22,178,911